Comment on the article Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes

Endocrinol Diabetes Nutr (Engl Ed). 2022 May;69(5):387-388. doi: 10.1016/j.endien.2022.05.007.

Authors

Sandro Gentile¹, Giuseppina Guarino², Ersilia Satta³, Felice Strollo⁴

Affiliations

¹ Vanvitelli University, School of Medicine, Naples, Italy; Nefrocenter Research and Nyx Start-up, Naples, Italy. Electronic address: s.gentile1949@gmail.com.
² Vanvitelli University, School of Medicine, Naples, Italy.
³ Nefrocenter Research and Nyx Start-up, Naples, Italy.
⁴ IRCCS San Raffaele Pisana, Rome, Italy.

PMID: 35697472
DOI: 10.1016/j.endien.2022.05.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes Mellitus, Type 1*
Humans
Insulin* / adverse effects
Risk Factors

Substances

Insulin